Many non diabetic patients benefit from improved appetite control balanced glucose levels and consistent weight loss
Ozempic is FDA-approved for the control of blood sugar in type 2 diabetes and decreasing the risk of major cardiovascular events, including death, in those with type 2 diabetes
Results were similar when limited to patients with class 2 or 3 obesity. According to the authors, compared with patients prescribed GLP-1s or no treatment, patients who underwent MBS were more medically complex, with 25.7% having four or more comorbidities compared with 22.7% of GLP1 users and 16.0% of untreated patients
Both medications are in the same class of drugs called GLP-1 receptor agonists, but they have different dosing schedules and side effect profiles
Come see us at 112 West Medical Aesthetics and Wellness and lets start this transformative journey together
has received honoraria from Viatris, Grnenthal, Eli Lilly, Sanofi and Procter & Gamble for educational meetings, investigator-led funding from Proctor & Gamble and received sponsorship to attend educational meetings from Daiichi Sankyo and Sanofi
